Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001726100-22-000002
Filing Date
2022-10-11
Accepted
2022-10-11 12:49:30
Documents
1
Effectiveness Date
2022-10-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8818
  Complete submission text file 0001726100-22-000002.txt   9868
Mailing Address 9000 CROW CANYON ROAD, STE. 620 DANVILLE CA 94506
Business Address 9000 CROW CANYON ROAD, STE. 620 DANVILLE CA 94506 (925) 399-7246
Elysium Therapeutics, Inc. (Filer) CIK: 0001726100 (see all company filings)

EIN.: 462769808 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-380638 | Film No.: 221303372